ALNY
Alnylam Pharmaceuticals Inc
Price:  
266.86 
USD
Volume:  
723,502.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam DCF Valuation - Growth Exit 5Y

-148.6%
Upside

What is the DCF valuation of Alnylam??

The Discounted Cash Flow (DCF) valuation of Alnylam Pharmaceuticals Inc (ALNY) is (129.56) USD. With the latest stock price at 266.86 USD, the upside of Alnylam Pharmaceuticals Inc based on DCF is -148.6%.

Is Alnylam a buy or a sell?

Based on the latest price of 266.86 USD and our DCF valuation, Alnylam Pharmaceuticals Inc (ALNY) is a sell. selling Alnylam stocks now will result in a potential gain of 148.6%.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
WACC / Discount Rate 7.3% - 9.3% 8.3%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price (235.71) - (90.77) (129.56)
Upside -188.3% - -134.0% -148.6%
266.86 USD
Stock Price
(129.56) USD
Fair Price